With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13885-09-1,2-(Diphenylphosphino)biphenyl,as a common compound, the synthetic route is as follows.
General procedure: To a solution of [Fe2(CO)6(m-SCH2CH2S)] (0.037 g, 0.1 mmol) and tris(4-methylphenyl)-phosphine (0.032 g, 0.1 mmol) in CH2Cl2 (5 mL) was added a solution of Me3NO2H2O(0.011 g, 0.1 mmol) in MeCN (5 mL). The mixture was stirred at room temperature for1 h and then the solvent was reduced on a rotary evaporator. The residue was subjectedto TLC using CH2Cl2/petroleum ether1:5 (v/v) as eluent. From the main redband, 0.054 g (83%) of 2 was obtained as a red solid., 13885-09-1
As the paragraph descriping shows that 13885-09-1 is playing an increasingly important role.
Reference£º
Article; Yan, Lin; He, Jiao; Liu, Xu-Feng; Li, Yu-Long; Jiang, Zhong-Qing; Wu, Hong-Ke; Journal of Coordination Chemistry; vol. 72; 15; (2019); p. 2531 – 2543;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate